There was no significant difference in the sensitivity of ARID1A wild type (OVCAR3, OVCAR5, ES2) and deficient (TOV21G, SKOV3, A2780) ovarian cancer lines to RA375 treatment (S3 Table) [37]. Here, ARID1A is linked to ovarian cancer.